Article
Multi-omics analysis of pediatric minimally differentiated acute myeloid leukemia reveals RUNX1-driven stemness and chemoresistance.
Leukemia - 1 Jul 2026
Kamitori Tatsuya, Saida Satoshi, Mitani Kazuki, Tsujimoto Shinichi, Goto Hiroaki, Shibata Hirofumi, Akazawa Ryo, Isobe Kiyotaka, Ueno Hiroo, Kakiuchi Nobuyuki, Saito Akiko M, Hiwatari Mitsuteru, Kudo Ko, Hirabayashi Shinsuke, Fukuoka Kohei, Koh Katsuyoshi, Taga Takashi, Kubota Hirohito, Kato Itaru, Umeda Katsutsugu, Adachi Souichi, Kawai Tomoko, Tomizawa Daisuke, Ikeda Junji, Shiba Norio, Hayashi Yasuhide, Ogawa Seishi, Takita Junko
Abstract excerpt
Minimally differentiated acute myeloid leukemia (AML-M0) is a rare and therapeutically challenging subgroup of AML characterized by immature hematopoietic stem cell-like features. To uncover the molecular basis, we conducted a comprehensive multi-omics analysis of 23 pediatric AML-M0 cases and compared them with 1483 leukemia samples. AML-M0 formed a characteristic group that exhibited global DNA hypermethylation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
